Fisetin
Fisetin is a pharmaceutical drug with 26 clinical trials. Currently 14 active trials ongoing. Historical success rate of 83.3%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
6
Early Stage
17
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
62.5%
5 of 8 finished
37.5%
3 ended early
14
trials recruiting
26
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Prevention of Frailty With Fisetin and Exercise in Breast Cancer Survivors
Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors
Medication Combinations of Dasatinib, Quercetin, Fisetin, Temozolomide, LMP744, and Autologous TLPO Vaccine for the Treatment of Previously Treated Glioma With Residual Disease
Ongoing Lung Decline With Age Intensified Response
Senolytics Treatment of Interstitial Lung Disease in Common Variable Immunodeficiency
Clinical Trials (26)
Prevention of Frailty With Fisetin and Exercise in Breast Cancer Survivors
Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors
Medication Combinations of Dasatinib, Quercetin, Fisetin, Temozolomide, LMP744, and Autologous TLPO Vaccine for the Treatment of Previously Treated Glioma With Residual Disease
Ongoing Lung Decline With Age Intensified Response
Senolytics Treatment of Interstitial Lung Disease in Common Variable Immunodeficiency
Alleviation by Fisetin of Frailty, Inflammation, and Related Measures in Older Adults
Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity
Fisetin Supplementation for Healthy Aging
Alleviation by Fisetin of Frailty, Inflammation, and Related Measures in Older Women
An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer
Fisetin to Reduce Senescence and Mobility Impairment in PAD
Fisetin in Mild Alzheimer's Disease
Inflammation and Stem Cells in Diabetic and Chronic Kidney Disease
A Study of Fisetin to Treat Carpal Tunnel Syndrome
Fisetin to Improve Vascular Function in Older Adults
COVID-FISETIN: Pilot in SARS-CoV-2 of Fisetin to Alleviate Dysfunction and Inflammation
COVID-FIS: Pilot in COVID-19 (SARS-CoV-2) of Fisetin in Older Adults in Nursing Homes
Enhancing Recovery Through a Combined Mechanobiologic Intervention Following Meniscus Repair
A Comparison of Fisetin Kinetics in Young and Old Adults
Effects of Botanical Microglia Modulators in Gulf War Illness
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 26